跳至主要内容
临床试验/ISRCTN91251359
ISRCTN91251359已完成不适用

The use of magnetic resonance in non-invasive pancreatic beta-cell imaging: the relation between pancreatic triglyceride accumulation and beta-cell function in human (pre)diabetes

VU University Medical Center, Diabetes Center (The Netherlands)0 个研究点目标入组 40 人开始时间: 2007年8月30日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Male and female subjects (aged 35-70 years)
  • 2. Impaired Fasting Glucose (IFG; plasma glucose > = 6.1 and < 7.0 mmol/l) and/or
  • 3. IFG (plasma glucose >= 5.6 and < 7.0 mmol/l) and a family history of Diabetes Mellitus type two (DM2; i.e. first and second degree [i.e. grandparents] relatives) and/or
  • 4. Impaired Glucose Tolerance (IGT; 2-hour plasma glucose during 75 g Oral Glucose Tolerance Test [OGTT] 7.8-11.1 mmol/l)

排除标准

  • 1. Known diabetes
  • 2. History or present liver, exocrine pancreatic or renal disease
  • 3. Drug-/alcohol abuse
  • 4. Acute cardiovascular disease <3 months prior to screening
  • 5. Malignant disease
  • 6. Claustrophobia and metal implants or pacemakers (MRI)
  • 7. Lack of capacity to understand the aim of the research
  • 8. Use of the following:
  • 8.1. Glucocorticoids
  • 8.2. Cytostatic drugs
  • 8.3. Thiazolidinediones
  • 8.4. Metformin
  • 8.5. Oral contraceptives
  • 8.6. Fibrates
  • 8.7. Anti epileptic drugs
  • 8.8. Centrally acting drugs for neurologic and/or psychiatric indications

研究者

发起方
VU University Medical Center, Diabetes Center (The Netherlands)

相似试验